Nath Bio-Genes (India) share news, announcements and annual reports
NSE: NATHBIOGENBSE: 537291Agricultural Food & other ProductsSmall Cap
Nath Bio-Genes (India) Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 2014
Last close ₹133.10down ₹0.32 (0.24%)BSE ₹133.00
Share price at the NSE close on 28 Oct 2026. Previous close ₹133.42.
28 Oct: open ₹133.50, high ₹134.94, low ₹132.43
52-week range of traded prices to 28 Oct 2026
₹126.15Low, 30 Mar 2026₹204.00High, 30 Apr 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹253 Cr2,134th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 6.91
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹7.21 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 8.60
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.37
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.50%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 5.5%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹7.21 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 4.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 5.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.20
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,02068.0% delivered
Nath Bio-Genes (India) has 336 announcements on record, routine notices left out; none in the 30 days to 29 Oct 2026, the latest on 24 Sep 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Nath Bio-Genes (India) quarterly results
Jul29Wed
The board met on 29 Jul 2026 to consider financial results
Notice filed 18 Jul 2026
To consider and approve the financial results for the period ended Jun 30, 2026
Nath Bio-Genes (India) annual reports, presentations and earnings calls
The company's own documents, latest first.Nath Bio-Genes (India) financials, year by year
Annual reports13
- Annual report, year to Mar 20261 Sep 2026
- Annual report, year to Mar 202531 Jul 2025
- Annual report, year to Mar 202423 Jul 2024
- Annual report, year to Mar 202317 Jun 2023, a zip file
- Annual report, year to Mar 20227 Jun 2022, a zip file
8 earlier reports
- Annual report, year to Mar 20215 Aug 2021, a zip file
- Annual report, year to Mar 20202 Jul 2020, a zip file
- Annual report, year to Mar 201919 Jul 2019, a zip file
- Annual report, year to Mar 201810 Aug 2018, a zip file
- Annual report, year to Mar 20178 Sep 2017, a zip file
- Annual report, year to Mar 20166 Aug 2016, a zip file
- Annual report, year to Mar 201517 Jul 2015, a zip file
- Annual report, year to Mar 20144 Jun 2014, a zip file
Investor presentations34
- Investor Presentation on Unaudited Financial Results as of 30th June 202630 Jul 2026
- Investor Presentation on Financial Results as on 31st March 20264 May 2026
- General Updates Investor Presentation on financial Results as on 31st December 202531 Jan 2026
- Presentation on financial results14 Nov 2025
- Presentation on financial results as on 30th June 202511 Jul 2025
29 earlier presentations
- Investor Presentation29 Apr 2025
- Investor Presentation on Financial Results as on 31st December 202425 Jan 2025
- Presentation on Unaudited financial results as on 30-09-202423 Oct 2024
- Investor Presentation7 Aug 2024
- Investor Presentation8 May 2024
- Investor Presentation18 Jan 2024
- Investor Presentation16 Oct 2023
- Investor Presentation10 Aug 2023
- Investor Presentation22 Apr 2023
- Investor Presentation14 Feb 2023
- Investor Presentation20 Oct 2022
- Investor Presentation for the quarter ended on 30th June 202213 Aug 2022
- Investor Presentation30 May 2022
- Investor Presentation14 Feb 2022
- Investor Presentation1 Nov 2021
- Investor Presentation10 Aug 2021
- Investor Presentation24 Jun 2021
- Investor Presentation12 Feb 2021
- Investor Presentation7 Nov 2020
- Investor Presentation8 Aug 2020
- Investor Presentation on financial results as on 31.03.202015 Jun 2020
- Investor Presentation30 Jan 2020
- Investor Presentation on unaudited financial results for the period ended 30th sep 20192 Nov 2019
- Investor Presentation5 Aug 2019
- Investor Presentation31 May 2019
- Investor Presentation15 Apr 2019
- Investor Presentation27 Sep 2018
- Investor Presentation20 Nov 2017, a zip file
- Corporate Presentation - August 2016.25 Aug 2016, a zip file
Earnings calls21
- Earning Call Transcript held on 05th May 202611 May 2026
- Transcript of concall18 Nov 2025
- Transcript2 May 2025
- Earning Call Transcript28 Oct 2024
- Audio transcript of con call held on 24th october 202425 Oct 2024
16 earlier call documents
- Audio transcript of con call held on 24th october 202425 Oct 2024
- Transcript14 May 2024
- Audio Recordings of Conference Call9 May 2024
- Transcript21 Oct 2023
- Link of Recording and17 Oct 2023
- Transcript27 Apr 2023
- Link of Recording25 Apr 2023
- Transcript of Analysts/Institutional Investor Meet/Con. Call2 Jun 2022
- Transcript of Concall8 Nov 2021
- Transcript of Con Call held on 12th February 202117 Feb 2021
- Transcript of Conference call held on 09th November 2020.19 Nov 2020
- Earning call transcript12 Aug 2020
- Transcript of Conference Call held on 16th June 2020.19 Jun 2020
- Analysts/Institutional Investor Meet/Con. Call Updates-Transcript of Conference call held on 31st January 20203 Feb 2020
- Analysts/Institutional Investor Meet/Con. Call Updates- Transcript of Conference call held on 04th Nov 20197 Nov 2019
- Analysts/Institutional Investor Meet/Con. Call Updates Transcript of Conference call held on 6th august 20199 Aug 2019
Nath Bio-Genes (India) share news and announcements
Newest first. Page 1 of 7.
Sep 2026
9 Sep · Legal
Exchange has sought clarification from Nath Bio-Genes (India) Limited for the quarter ended 30-Jun-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: The response of the Company is awaited.5 Sep · Board meeting
4 Sep · Board meeting
1 Sep · Corporate action
Aug 2026
Jul 2026
30 Jul
29 Jul · Results
18 Jul · Board meeting
Jun 2026
May 2026
11 May
11 May
4 May
4 May · Results
Apr 2026
29 Apr · General Updates
Jan 2026
31 Jan · Results
24 Jan · Board meeting
Nov 2025
13 Nov · Results
Sep 2025
4 Sep · Legal
Exchange has sought clarification from Nath Bio-Genes (India) Limited for the quarter ended 30-Jun-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted in XBRL with discrepancies The response of the Company is awaited.
Aug 2025
Jul 2025
31 Jul · Corporate action
31 Jul · Meeting
11 Jul · Results
4 Jul · Board meeting
3 Jul · Management
Jun 2025
May 2025
Apr 2025
30 Apr · Management
29 Apr · Results
24 Apr · Analysts
Jan 2025
23 Jan · Results
15 Jan · Board meeting
Oct 2024
23 Oct · Management
23 Oct · Board meeting
23 Oct · Results
19 Oct · Analysts
17 Oct · Board meeting
Aug 2024
19 Aug · Legal
Exchange has sought clarification from Nath Bio-Genes (India) Limited for the quarter ended 30-Jun-2024 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited.
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts). Delivery against usual in the glossary
- 7 Sep 2026Dividenddown 0.31%+0.1 pts vs Nifty 500market median 0.0% · five sessions −3.5% (−1.8 pts vs Nifty 500) · volume 0.4× usual · delivery +7.3 pts against usual · The announcement
- 30 Jul 2026Resultsup 0.89%+0.9 pts vs Nifty 500market median −0.7% · five sessions +3.0% (+1.4 pts vs Nifty 500) · volume 9.0× usual · delivery −26.7 pts against usual · The announcement
- 5 May 2026Resultsdown 8.43%−8.3 pts vs Nifty 500market median −0.7% · five sessions −10.7% (−10.6 pts vs Nifty 500) · volume 3.0× usual · delivery −17.8 pts against usual · The announcement
- 1 Feb 2026Resultsdown 1.77%+0.3 pts vs Nifty 500market median −0.7% · five sessions +1.1% (−0.4 pts vs Nifty 500) · volume 1.2× usual · delivery +3.9 pts against usual · The announcement
- 14 Nov 2025Resultsup 1.33%+1.2 pts vs Nifty 500market median −0.7% · five sessions −2.3% (−3.0 pts vs Nifty 500) · volume 1.2× usual · delivery +2.8 pts against usual · The announcement
- 14 Jul 2025Resultsdown 5.00%−5.1 pts vs Nifty 500market median −0.7% · five sessions −14.2% (−14.1 pts vs Nifty 500) · volume 0.3× usual · The announcement
- 3 Jul 2025Board or managers changedup 3.28%+3.4 pts vs Nifty 500market median 0.0% · five sessions +15.1% (+15.1 pts vs Nifty 500) · volume 0.8× usual · delivery +0.7 pts against usual · The announcement
- 2 May 2025Board or managers changedup 1.15%+1.3 pts vs Nifty 500market median 0.0% · five sessions +2.5% (+3.4 pts vs Nifty 500) · volume 0.7× usual · delivery +2.0 pts against usual · The announcement
- 30 Apr 2025Board or managers changeddown 0.32%0.0 pts vs Nifty 500market median 0.0% · five sessions +1.6% (+1.8 pts vs Nifty 500) · volume 1.5× usual · delivery −3.6 pts against usual · The announcement
- 24 Oct 2024Resultsdown 4.19%−4.0 pts vs Nifty 500market median −0.7% · five sessions −6.1% (−5.7 pts vs Nifty 500) · volume 4.3× usual · delivery +10.7 pts against usual · The announcement
16 earlier announcements
- 24 Oct 2024Board or managers changeddown 4.19%−4.0 pts vs Nifty 500market median 0.0% · five sessions −6.1% (−5.7 pts vs Nifty 500) · volume 4.3× usual · delivery +10.7 pts against usual · The announcement
- 9 May 2024Dividenddown 5.29%−3.5 pts vs Nifty 500market median 0.0% · five sessions −7.8% (−8.0 pts vs Nifty 500) · volume 1.7× usual · delivery +9.1 pts against usual · The announcement
- 19 Jan 2024Resultsup 10.49%+9.5 pts vs Nifty 500market median −0.7% · five sessions +5.3% (+5.5 pts vs Nifty 500) · volume 17.3× usual · delivery −30.0 pts against usual · The announcement
- 24 Apr 2023Dividenddown 3.95%−4.5 pts vs Nifty 500market median 0.0% · five sessions −2.0% (−4.5 pts vs Nifty 500) · volume 4.5× usual · delivery −5.1 pts against usual · The announcement
- 24 Apr 2023Resultsdown 3.95%−4.5 pts vs Nifty 500market median −0.7% · five sessions −2.0% (−4.5 pts vs Nifty 500) · volume 4.5× usual · delivery −5.1 pts against usual · The announcement
- 16 Aug 2022Resultsdown 0.45%−1.4 pts vs Nifty 500market median −0.7% · five sessions −2.8% (−1.9 pts vs Nifty 500) · volume 0.5× usual · delivery +11.5 pts against usual · The announcement
- 20 Jul 2022Board or managers changedup 5.82%+5.0 pts vs Nifty 500market median 0.0% · five sessions −5.7% (−6.3 pts vs Nifty 500) · volume 5.2× usual · delivery +3.0 pts against usual · The announcement
- 31 May 2022Resultsdown 8.75%−8.5 pts vs Nifty 500market median −0.7% · five sessions −9.4% (−8.7 pts vs Nifty 500) · volume 5.6× usual · delivery −17.2 pts against usual · The announcement
- 25 Jun 2021Dividenddown 5.37%−5.9 pts vs Nifty 500market median 0.0% · five sessions −7.6% (−7.5 pts vs Nifty 500) · volume 1.2× usual · delivery +8.1 pts against usual · The announcement
- 11 Feb 2021Resultsdown 0.31%−0.8 pts vs Nifty 500market median −0.7% · five sessions +2.6% (+1.5 pts vs Nifty 500) · volume 0.8× usual · delivery +3.5 pts against usual · The announcement
- 9 Nov 2020Resultsdown 4.56%−6.0 pts vs Nifty 500market median −0.7% · five sessions −1.0% (−4.5 pts vs Nifty 500) · volume 1.8× usual · delivery +15.5 pts against usual · The announcement
- 10 Aug 2020Credit ratingdown 10.58%−11.3 pts vs Nifty 500market median 0.0% · five sessions −17.7% (−17.8 pts vs Nifty 500) · volume 6.5× usual · delivery −7.4 pts against usual · The announcement
- 15 Jun 2020Resultsup 4.92%+6.3 pts vs Nifty 500market median −0.7% · five sessions +2.4% (−0.2 pts vs Nifty 500) · volume 1.9× usual · delivery −29.6 pts against usual · The announcement
- 4 Nov 2019Resultsdown 3.91%−4.2 pts vs Nifty 500market median −0.7% · five sessions +2.8% (+3.0 pts vs Nifty 500) · volume 2.0× usual · delivery −18.3 pts against usual · The announcement
- 28 Jun 2018Board or managers changeddown 0.67%+0.3 pts vs Nifty 500market median 0.0% · five sessions +14.0% (+13.2 pts vs Nifty 500) · volume 1.1× usual · delivery −5.7 pts against usual · The announcement
- 21 Jun 2018Credit ratingdown 1.70%−1.3 pts vs Nifty 500market median 0.0% · five sessions −9.3% (−7.7 pts vs Nifty 500) · volume 0.3× usual · delivery +7.9 pts against usual · The announcement
Nath Bio-Genes (India) results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.
Figures filed again
Lines the company later filed with a different value, rupee lines in ₹ crore and per-share lines in rupees.
| Line | Period | Accounts | First filed | Filed again | Change. The value filed again less the value first filed, as a per cent of the first. | First filed on | Filed again on |
|---|---|---|---|---|---|---|---|
| Tax on other comprehensive income that stays out of profit | Quarter to Jun 2026 | Consolidated | −0.02 | 0.02 | +177.8% | 29 Jul 2026 | 18 Sep 2026 |
| Tax on other comprehensive income that stays out of profit | Quarter to Jun 2026 | Standalone | −0.02 | 0.02 | +177.8% | 29 Jul 2026 | 18 Sep 2026 |